HIV Resistance Due to ARV Use Only During Pregnancy
Researchers in the P1022 Study Team found evidence of drug resistance frequently in women who stopped ARVs (either nelfinavir-based or nevirapine-based) after delivery. This resistance was more frequent for women on the nelfinavir-based treatment protocol. Research suggests that adherence may be more lax among women who discontinue ARV use postpartum.
Citation:
Ellis GM, Huang S, Hitti J, Frenkel LM, P1022 Study Team. Selection of HIV resistance associated with antiretroviral therapy initiated due to pregnancy and suspended postpartum. J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):241-7.
Abstract
Original Article (subscription may be required)
Citation:
Ellis GM, Huang S, Hitti J, Frenkel LM, P1022 Study Team. Selection of HIV resistance associated with antiretroviral therapy initiated due to pregnancy and suspended postpartum. J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):241-7.
Abstract
Original Article (subscription may be required)
